STOCK TITAN
  1. Home
  2. News
  3. INBS

Intelligent Bio Solutions Inc - INBS STOCK NEWS

Welcome to our dedicated page for Intelligent Bio Solutions news (Ticker: INBS), a resource for investors and traders seeking the latest updates and insights on Intelligent Bio Solutions stock.

Intelligent Bio Solutions Inc (INBS) delivers innovative diagnostic solutions through its biosensor platform and fingerprint-based drug screening systems. This news hub provides investors and healthcare professionals with timely updates on the company’s advancements in non-invasive testing technologies.

Access comprehensive coverage of earnings reports, regulatory milestones, and product development progress. Stay informed about strategic partnerships and clinical validation studies that shape INBS’s position in life sciences. Our curated news collection simplifies tracking critical developments in portable drug screening and chronic disease monitoring solutions.

Discover updates on the Intelligent Fingerprinting Products segment’s commercial deployments and the evolving Biosensor Platform Technology applications. Bookmark this page for efficient monitoring of INBS’s contributions to modern healthcare diagnostics and workplace safety innovations.

News

Intelligent Bio Solutions Inc. Announces Closing of $4.378 Million Underwritten Public Offering Including Partial Exercise of Underwriters’ Overallotment Option

Rhea-AI Summary
Intelligent Bio Solutions Inc. closes underwritten public offering of units for $4.378 million, with proceeds to be used for general corporate purposes and working capital.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.14%
Tags
offering
-
News

Intelligent Bio Solutions Inc. Announces Pricing of $4,000,000 Underwritten Public Offering

Rhea-AI Summary
Intelligent Bio Solutions Inc. announces pricing of underwritten public offering of units for $4.0 million. Offering consists of 7,272,727 shares of common stock, warrants, and convertible preferred stock. Proceeds to be used for general corporate purposes and working capital.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-53.5%
Tags
offering
-
News

Intelligent Bio Solutions Obtains ISO Recertification for its Intelligent Fingerprinting Drug Screening Business

Rhea-AI Summary
Intelligent Bio Solutions Inc. (Nasdaq: INBS) has obtained recertification for ISO 13485:2016, a quality management system standard for the medical device industry. The recertification is valid for three years and supports the company's expansion plans into North America and Asia Pacific regions. The ISO 13485:2016 certification confirms the company's ability to meet the highest quality criteria globally. The company's Intelligent Fingerprinting Drug Screening System has gained positive feedback from over 350 clients worldwide.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
News

Intelligent Bio Solutions Completes Critical Development Milestone in Plans to Add Ketamine and Tramadol to Fingerprint Drug Test

Rhea-AI Summary
Intelligent Bio Solutions announces successful completion of key milestone in adding ketamine and tramadol to its drug screening system
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.29%
Tags
none
-
News

Intelligent Bio Solutions Inc. Reports Fiscal 2023 Fourth Quarter and Full Year Financial Results and Operational Highlights

Rhea-AI Summary
Intelligent Bio Solutions reports 355% YoY increase in combined revenue and government support income, receives FDA guidance on regulatory pathway for Intelligent Fingerprinting Drug Screening Cartridge, and secures 8 new customers in Australia. Net loss for FY 2023 was $10.6M.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.1%
Tags
earnings
-
News

Intelligent Bio Solutions Secures 8 New Customers with a Combined Workforce of Over 10,000 Employees Two Months into Product Launch in Australia

Rhea-AI Summary
Intelligent Bio Solutions announces securing 8 new customers in Australia for its Intelligent Fingerprinting Drug Screening System, highlighting growing demand for alternative screening solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.33%
Tags
none
News

Intelligent Bio Solutions Signs South American Distribution Agreement with TSCOM for Fingerprint Drug Screening System and Secures First Order

Rhea-AI Summary
Intelligent Bio Solutions Inc. has signed a distribution agreement with TSCOM SPA for its Intelligent Fingerprinting Drug Screening System, expanding its availability in South America. The company has received its first order from a Chile-based electrical distribution company. The fingerprint-based drug testing system analyzes fingerprint sweat to screen for recent drug use, providing a quick, easy, non-invasive alternative to traditional testing methods. TSCOM SPA will offer local service and support for customers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.66%
Tags
none
-
News

Intelligent Bio Solutions Receives Guidance from U.S. FDA on a Regulatory Pathway for Expansion into the United States for its Intelligent Fingerprinting Drug Screening Cartridge

Rhea-AI Summary
Intelligent Bio Solutions announces FDA guidance on regulatory classification of its Intelligent Fingerprinting Drug Screening Cartridge
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.89%
Tags
none
-
News

Intelligent Bio Solutions Receives Non-Dilutive Grant Funding of USD $1.43 Million

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.33%
Tags
none
News

Intelligent Bio Solutions to Participate in the LD Micro Invitational XIII on June 6th

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.25%
Tags
conferences
Stock INBS logo
Intelligent Bio Solutions Inc

Nasdaq:INBS

INBS Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

INBS Stock Data

8.07M
6.69M
1.89%
1.27%
6.7%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
NEW YORK